Recursion
Pioneering AI-driven drug discovery to decode biology and radically improve lives
Key strengths
Facts verified against recursion.com on
Get alerts when Recursion changes
Free. We'll email you when pricing, the free tier, API access or open-source status changes.
Recursion – Technical Use Cases
Recursion OS and its underlying infrastructure are relevant to the following technical and partnership contexts:
1. AI-Augmented Target Identification
Recursion's ML models, trained on 50+ petabytes of proprietary biological data, can surface non-obvious disease targets by detecting subtle phenotypic patterns across millions of cellular experiments — a task intractable with conventional bioinformatics pipelines alone.
2. High-Throughput Phenotypic Screening at Scale
With up to 2 million experiments per week, Recursion's automated wet-lab infrastructure enables phenotypic screening programs at a throughput that far exceeds standard CRO or internal pharma capabilities, making it suitable for large-scale target or compound class validation.
3. Generative De Novo Chemistry
Recursion's generative AI models design novel chemical structures optimized for biological activity, bypassing the limitations of traditional compound library screening. This is applicable in hit generation and scaffold-hopping scenarios where existing chemical matter is insufficient.
4. Compound Funnel Optimization
By leveraging predictive models to prioritize candidates early, Recursion reduces the number of compounds required by approximately 90% versus industry norms — directly compressing lead identification and optimization timelines for partnered programs.
5. Oncology and Rare Disease Pipeline Partnering
Pharmaceutical and biotech partners can access Recursion's clinical-stage pipeline in oncology and rare disease, leveraging the platform's integrated data and automation infrastructure for co-development or licensing arrangements.